Vesalius Biocapital III Partners SàRL
Series B → Growth
Their stated focus (public profile)
Vesalius Biocapital is a European life sciences venture capital investor focused on later-stage companies in drug development, medical devices & diagnostics, and eHealth/mHealth, predominantly in Europe. Portfolio companies must address unmet medical and market needs and operate on the basis of strong intellectual property protection. The active fund, Vesalius Biocapital III, closed in May 2019 with €120 million in commitments.
Stages: Series B → Growth
Sectors: Life sciences, Medtech, Ehealth, Mhealth
On file: 3 companies on record
Website: vesaliusbiocapital-3.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.